Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts. The British journal of dermatology. 2017;176(3):643-9.

28/02/2022

García-Doval I, Hernández MV, Vanaclocha F, Sellas A, de la Cueva P, Montero D.

Epub 2016/06/04. doi: 10.1111/bjd.14776. PubMed PMID: 27258623.